SIBN Stock Analysis

Si-Bone Inc
HEALTHCARE MEDICAL DEVICES

Back to Winners View Yahoo Finance Chart Buy on the Dip
Strong Caution Mixed Weak Unavailable
StockValueFinder Grade
F
33.76 / 100
Weak
Confidence: High (80.0%) Coverage: 80.0%
Business Quality 5.5
Financial Strength 45.3
Earnings & Growth 50.0
Valuation 32.0
Market Strength 46.2
The grade combines Business Quality, Financial Strength, Earnings & Growth, Valuation, and Market Strength. Rating and Trend remain separate signals.
Rating AVOID
Avoid
The screening rules are warning against this setup.
Rating is the simple decision label from the screening rules.
Trend STRONG BUY TREND
Bullish
The available trend signal is constructive.
Trend shows whether price action is helping or hurting the setup.
P/E Ratio -48.82
Not Meaningful
Negative or missing earnings make P/E hard to use.
P/E shows how much investors pay for each dollar of earnings.
ROIC -10.58%
Poor
Negative ROIC suggests capital is not being used profitably.
ROIC measures how efficiently capital turns into profit.
Debt Payback -3.91 yrs
Unavailable
Debt payback is unavailable or not meaningful.
Debt payback estimates how quickly debt could be covered.
Interest Coverage -4.23x
Poor
Negative coverage means earnings are not covering interest costs.
Interest coverage shows how easily earnings cover interest costs.
Price $21.48
Market Price
Price alone is not a buy or sell signal.
Price should be judged with valuation, quality, and trend.
Last updated: 2026-10-25 02:00:24

Performance Overview

Trailing adjusted-close returns as of 2026-07-27. Benchmark is SPY.

YTD Return

SIBN -13.54%
SPY +8.96%

1-Year Return

SIBN -1.16%
SPY +17.29%

3-Year Return

SIBN -31.75%
SPY +69.55%

5-Year Return

SIBN -41.29%
SPY +80.16%

Returns are calculated from adjusted close prices and may differ from broker or research-site totals depending on data source, dividend handling, benchmark choice, and latest available trading date.

Legacy Screening Checks

This page uses cached SQL data from the latest StockValueFinder scan, so it loads fast without hitting Alpha Vantage on every page view.

50%
EPS Strength
FAIL

Looks for positive and improving earnings per share.

ROIC 10%+
FAIL

Looks for strong return on invested capital.

Interest Coverage 6+
FAIL

Checks whether operating income comfortably covers interest expense.

Debt Payback ≤ 3 Years
PASS

Checks whether free cash flow could pay down long-term debt quickly.

P/E 15 or Less
PASS

Checks whether valuation is reasonable under the current rule set.

Moving Average Trend
STRONG BUY TREND

Uses 20-day, 50-day, and 200-day moving averages for entry timing context.

A high StockValueFinder score is a research signal, not a guarantee. Strong companies can still fall during recessions, sector downturns, valuation resets, or company-specific events. Always review the business, risks, SEC filings, valuation, and your personal investment goals before buying.

Cached Technical Data

Moving average values from the latest stored scan.

20-Day MA19.64
50-Day MA19.17
200-Day MA16.33
MA Score5

Latest Published Stock Research

Research generated: October 23, 2026

SIBN Stock Analysis: Why Si-Bone Inc Scored 50% in Stock Value Finder

Analyzing Si-Bone Inc (SIBN): A Comprehensive Educational Review of Financial Metrics and Risk Profiles

This article serves as a detailed educational research review of Si-Bone Inc (SIBN), conducted by the StockValueFinder.com analysis system. The purpose of this report is not to provide a recommendation, but to deconstruct the specific financial metrics associated with SIBN. By examining these numbers through a disciplined, hard-money lens, investors can learn how to evaluate the structural integrity of a company's balance sheet and its ability to preserve purchasing power in an uncertain economic environment.

Si-Bone Inc (SIBN) operates within the Healthcare sector, specifically focusing on the Medical Devices industry. In an era characterized by fluctuating interest rates and concerns regarding long-term currency stability, understanding the fundamental health of a medical device company is critical. Investors must distinguish between companies that generate real economic value and those that may be consuming capital without a clear path to sustainable profitability.

Why the StockValueFinder Score Matters

The StockValueFinder score for Si-Bone Inc (SIBN) is 50%, resulting in an overall rating of AVOID. This score is a composite metric derived from several quantitative tests, including earnings quality, capital efficiency, debt obligations, and valuation discipline.

A score of 50% indicates a lack of consensus among the fundamental metrics; while some technical or structural indicators may show strength, the core financial health indicators are failing to meet established thresholds for high-quality investing. In professional analysis, a rating of "AVOID" is utilized when the mathematical risks—such as negative returns on capital or insufficient interest coverage—outweigh the perceived benefits of the stock's current price action. This score is designed to help students of the market identify companies that may lack the defensive characteristics necessary to withstand economic volatility.

EPS Strength and Consistency

Earnings Per Share (EPS) is a fundamental metric used to determine how much profit a company generates for each outstanding share of its common stock. Consistency in EPS is vital because it demonstrates a company's ability to generate actual cash flow rather than relying on accounting maneuvers or dilutive capital raises.

For Si-Bone Inc (SIBN), the system recorded an EPS test result of "Did not pass." While the specific historical EPS dollar values were not supplied in this data set, the failure of the test indicates that the company's earnings history does not meet the required standards for stability or profitability.

To learn how to evaluate other stocks, consider this: An attractive EPS profile typically shows steady or growing positive earnings over several years. For example, a company that consistently grows its EPS from $1.00 to $1.20 to $1.50 shows "earnings quality." Conversely, a company with highly volatile or negative EPS is often viewed as high-risk because it lacks the predictable cash flow needed to fund operations or reward shareholders without increasing debt.

ROIC and Capital Efficiency

Return on Invested Capital (ROIC) is one of the most critical metrics for a disciplined investor. It measures how effectively a company uses its capital (both debt and equity) to generate profits. In an environment where inflation can erode the real value of money, a company must earn a return that significantly exceeds its cost of capital to truly create wealth.

The reported ROIC for Si-Bone Inc (SIBN) is -10.58%.

StockValueFinder generally prefers an ROIC of 10% or higher. A positive, double-digit ROIC suggests that a company is an efficient "wealth creator." For example, a company with a 15% ROIC is using its capital much more effectively than a company with a 4% ROIC, as the former is generating significantly more value for every dollar deployed. A negative ROIC, such as SIBN's -10.58%, indicates that the company is actually destroying value by losing money on the capital it has deployed. This is a significant red flag for long-term investors concerned with capital preservation.

Interest Coverage and Financial Safety

Interest coverage is a solvency ratio that measures how easily a company can pay the interest expenses on its outstanding debt. This is a vital metric for assessing "financial safety." When interest rates rise, companies with low interest coverage face increased pressure, as the cost of servicing their debt can consume an increasing portion of their operating income.

For Si-Bone Inc (SIBN), the interest coverage test resulted in "Did not pass."

StockValueFinder prefers an interest coverage ratio of 6 or higher. A high ratio provides a "margin of safety." For example, an interest coverage of 8x means the company earns eight times more than it needs to cover its interest payments, providing a buffer against earnings volatility. A company with 2x coverage is much more vulnerable; if its income drops even slightly, it may struggle to meet its legal obligations to lenders. Because SIBN failed this test, the company's ability to manage its debt obligations in a tightening credit environment is considered a risk.

Debt Payback and Balance Sheet Discipline

Debt payback (often expressed in years) estimates how long it would take a company to pay back its total debt using its current cash flow or earnings. This metric helps investors understand the company's level of leverage and its long-term solvency.

The reported debt payback for Si-Bone Inc (SIBN) is -3.91 years.

StockValueFinder prefers a debt payback period of 3 years or less. A lower number indicates a more liquid and disciplined balance sheet. For example, a company with 1.5 years of debt payback is in an attractive position because it can clear its obligations quickly. While the system marked the debt payback test as "Passed" for SIBN, the negative number (-3.91) is an anomaly that requires careful reading of the underlying data. In standard financial modeling, a negative payback period often indicates mathematical inconsistencies or specific accounting treatments that do not align with traditional "healthy" debt structures.

P/E Ratio and Valuation Discipline

The Price-to-Earnings (P/E) ratio is a valuation metric that compares a company's current share price to its earnings per share. It tells an investor how much they are paying for every $1 of profit the company generates.

The reported P/E ratio for Si-Bone Inc (SIBN) is -48.82.

StockValueFinder prefers a P/E of 15 or lower for valuation discipline. A low P/E ratio often suggests a "value" opportunity, whereas a high P/E suggests the market has priced in significant future growth. For example, a P/E of 8 may be more value-oriented than a P/E of 40, assuming the business quality is sound. However, because SIBN has a negative P/E of -48.82, the company is currently reporting losses rather than profits. While the system marked the P/E valuation test as "Passed," this is typically a technical pass indicating that the metric is being calculated, but a negative P/E fundamentally means there are no earnings to value against the price.

Moving Average Trend and Entry Timing

While fundamental analysis looks at the "what" and "why" of a company, technical indicators like moving averages look at the "when." Moving averages are used to identify the direction of a stock's price momentum.

The moving average signal for Si-Bone Inc (SIBN) is a "STRONG BUY TREND."

It is crucial to understand that a trend signal is used for timing discipline, not as proof that the stock must rise. A "Strong Buy Trend" simply means the recent price action is moving upward relative to its historical averages. However, a technical trend can exist even in a company with poor fundamentals (a phenomenon often seen in speculative trading).

Regarding entry timing, the system provided "N/A" for the following

Entry signal: N/A - Entry status: N/A - Limit buy idea: N/A - Pullback zone: N/A - Risk stop / trend risk level: N/A

These "N/A" designations mean that the system has not identified specific mathematical price levels for entering or exiting a position. These categories are intended to be educational reference levels, not buy or sell orders.

Overall Financial Strengths and Weaknesses

In summary, the financial profile of Si-Bone Inc (SIBN) presents a significant dichotomy between its price momentum and its fundamental health.

**Strengths:** - **Price Momentum:** The stock is currently exhibiting a "STRONG BUY TREND" according to moving average signals, suggesting short-term upward momentum.

**Weaknesses:** - **Profitability:** The company has a negative ROIC (-10.58%) and a negative P/E ratio (-48.82), indicating it is currently losing money and destroying capital. - **Earnings Quality:** The EPS test was failed, suggesting a lack of consistent earnings history. - **Solvency Risks:** The interest coverage test was failed, indicating potential difficulty in servicing debt. - **Valuation Uncertainty:** The combination of negative earnings and a strong technical trend often characterizes high-volatility environments where fundamental value is disconnected from price action.

Risks and Limitations

Investors must be aware of the inherent risks in analyzing companies with negative earnings and negative ROIC. In a regime of high government debt and potential currency instability, companies that cannot generate their own cash flow are heavily dependent on external financing. If credit markets tighten or interest rates remain elevated, companies that fail the interest coverage test face a heightened risk of insolvency.

Furthermore, technical trends (like the "Strong Buy Trend" seen here) can be deceptive. They reflect past price movement and do not account for future fundamental shifts, such as changes in healthcare regulations, medical device competition, or macroeconomic shocks.

This research is limited to the data provided and does not account for unannounced news, pending litigation, or shifts in the broader healthcare regulatory landscape.

Educational Conclusion

Through this analysis of Si-Bone Inc (SIBN), we can observe how a stock might appear attractive on a technical basis (Strong Buy Trend) while being fundamentally weak according to strict value-investing criteria (Negative ROIC, Failed Interest Coverage, and Negative EPS).

A disciplined investor uses these metrics to build a "moat" around their capital. By requiring high ROIC, positive EPS, and strong interest coverage, an investor seeks to avoid companies that may require constant infusions of new capital just to survive. SIBN serves as a textbook example of why looking at a single metric—like price trend—is insufficient for a complete understanding of investment risk.

This article is for research and educational purposes only. It is not personal financial advice, investment advice, or a recommendation to buy or sell any security.


Research links: Yahoo Finance | Seeking Alpha | Finviz | SEC Filings

Research Attribution
Mac Gemton IV

Mac Gemton IV is a financial research analyst specializing in equity valuation, ETF performance, dividend income strategies, and investment risk assessment. With a disciplined, data-driven approach, he examines company fundamentals, earnings growth, balance-sheet strength, valuation ratios, historical returns, and market trends. His research focuses on identifying financial strengths, potential risks, and long-term investment considerations, transforming complex financial data into clear, practical analysis for everyday investors.

30-Day Trendline Analysis

Optional intraday chart with rising support, falling resistance, and multi-timeframe views.

Load detailed price structure only when needed. Downloads roughly 30 days of 5-minute candles, identifies swing points, then calculates validated support and resistance lines.
Scroll to Top